fbpx Advances in Drug Discovery: From Human Genetic Signatures to Drug Targets - Videos | JLABS

Advances in Drug Discovery: From Human Genetic Signatures to Drug Targets

06/29/2021 JLABS @ BE
00:23:17
JJI_EMEA_Assignment1_Video1_WithCaptions_052021

Advances in Drug Discovery: From Human Genetic Signatures to Drug Targets

Johnson & Johnson Innovation, together with Janssen Research & Development, invited scientific experts and entrepreneurs for a discussion on harnessing the next wave of science and innovation in translating human genetic signatures to causal inference for disease.

Related Videos

Part 2

Part 3

Part 4

Check out more On-Demand Webinars

Please note: This webinar will be a rebroadcast of the recording which took place May 5, 2021.

You are watching a rebroadcast of the webinar. There will not be a live Q&A session following the presentation. If you have any questions for the speakers, please email  [email protected]

DISCLAIMER: The information on this webpage, including in the videos, is proprietary or licensed to Johnson & Johnson Innovation LLC, its parent company or any affiliate companies (“JJI”) and is for informational purposes only.  This content is not intended to influence the use, sale, recommendation, or promotion of any products or services of Johnson & Johnson or its affiliates.  The information presented in the videos is specific and applicable to region in which the original presentation took place. Many videos contain information from, or sessions given by, third parties. Please note that only those third parties that provide this information are responsible for it. By providing this information, JJI does not endorse these third parties or any of the information provided in these videos, and JJI makes no representations, warranties, or assurances, express or implied, as to the content or the information presented and is not responsible for any use of this information by you.                   


Related content